Diagnosis and treatment of cholangiocarcinoma
暂无分享,去创建一个
[1] H. Thomas,et al. Guidelines for the diagnosis and treatment of cholangiocarcinoma: consensus document , 2002, Gut.
[2] A. Stiehl,et al. Value of Brush Border Cytology for Dominant Strictures in Primary Sclerosing Cholangitis , 1999, Endoscopy.
[3] D. Bluemke,et al. MR imaging of intrahepatic cholangiocarcinoma: use of ferumoxides for lesion localization and extension. , 2001, AJR. American journal of roentgenology.
[4] S. Hesse,et al. Positron emission tomography with [18F]fluoro‐2‐deoxy‐D‐glucose for diagnosis and staging of bile duct cancer , 2001 .
[5] R. Hruban,et al. Clinical value of K-ras codon 12 analysis and endobiliary brush cytology for the diagnosis of malignant extrahepatic bile duct stenosis. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.
[6] M. Tempero,et al. Radiochemotherapy and Transplantation Allow Long‐Term Survival For Nonresectable Hilar Cholangiocarcinoma , 2002, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[7] S. Hesse,et al. Positron emission tomography with [(18)F]fluoro-2-deoxy-D-glucose for diagnosis and staging of bile duct cancer. , 2001, Hepatology.
[8] J. Soto,et al. Malignant hilar and perihilar biliary obstruction: use of MR cholangiography to define the extent of biliary ductal involvement and plan percutaneous interventions. , 2001, Radiology.
[9] W. Bechstein,et al. Extended resections for hilar cholangiocarcinoma. , 1999, Annals of surgery.
[10] K. Boberg,et al. Cholangiocarcinoma in Primary Sclerosing Cholangitis: Risk Factors and Clinical Presentation , 2002, Scandinavian journal of gastroenterology.
[11] P. Johnson,et al. Plasma nucleic acids in the diagnosis and management of malignant disease. , 2002, Clinical chemistry.
[12] H. Thomas,et al. Increase in mortality rates from intrahepatic cholangiocarcinoma in England and Wales 1968–1998 , 2001, Gut.
[13] M. Levy,et al. Evaluation of the pancreaticobiliary ductal systems by intraductal US. , 2002, Gastrointestinal endoscopy.
[14] G. Gores,et al. Preliminary experience with liver transplantation in selected patients with unresectable hilar cholangiocarcinoma. , 2002, Surgical oncology clinics of North America.
[15] T. Therneau,et al. Improved diagnostic yield of endoscopic biliary brush cytology by digital image analysis. , 2001, Mayo Clinic proceedings.
[16] T. Hwang,et al. Malignant perihilar biliary obstruction: magnetic resonance cholangiopancreatographic findings , 2000, American Journal of Gastroenterology.
[17] R. Felix,et al. Magnetic resonance cholangiopancreatography-guided unilateral endoscopic stent placement for Klatskin tumors. , 2001, Gastrointestinal endoscopy.
[18] A. Tannapfel,et al. Photodynamic therapy for advanced bile duct cancer: Evidence for improved palliation and extended survival , 2000, Hepatology.
[19] A. Bergquist,et al. Diagnosis of biliary strictures in conjunction with endoscopic retrograde cholangiopancreaticography, with special reference to patients with primary sclerosing cholangitis. , 2002, Endoscopy.
[20] G. D. De Palma,et al. Unilateral versus bilateral endoscopic hepatic duct drainage in patients with malignant hilar biliary obstruction: results of a prospective, randomized, and controlled study. , 2001, Gastrointestinal endoscopy.
[21] M. E. Ryan,et al. Comparison of flow cytometry for DNA content and brush cytology for detection of malignancy in pancreaticobiliary strictures. , 1994, Gastrointestinal endoscopy.
[22] R. Lothe,et al. Intradermal ras peptide vaccination with granulocyte‐macrophage colony‐stimulating factor as adjuvant: Clinical and immunological responses in patients with pancreatic adenocarcinoma , 2001, International journal of cancer.
[23] K. Endo,et al. Cyclooxygenase-2 and ERBB-2 in Cholangiocarcinoma: Potential Therapeutic Targets , 2002, Seminars in liver disease.
[24] M. Miyazaki,et al. Results of surgical treatment for intrahepatic cholangiocarcinoma and clinicopathological factors influencing survival , 2002, The British journal of surgery.
[25] E. Fishman,et al. Intrahepatic cholangiocarcinoma: the role of imaging in detection and staging. , 1997, Critical reviews in diagnostic imaging.
[26] G. Gores,et al. Biliary tract cancers. , 1999, The New England journal of medicine.
[27] K. Lillemoe,et al. Surgery for hilar cholangiocarcinoma: the Johns Hopkins approach. , 2000, Journal of hepato-biliary-pancreatic surgery.
[28] K. Boberg,et al. Cholangiocarcinoma in primary sclerosing cholangitis: K-ras mutations and Tp53 dysfunction are implicated in the neoplastic development. , 2000, Journal of hepatology.
[29] J. Burdick,et al. In situ hybridization for telomerase RNA in routine cytologic brushings for the diagnosis of pancreaticobiliary malignancies. , 1998, Gastrointestinal endoscopy.
[30] Randall G. Lee,et al. Liver resection for hilar and peripheral cholangiocarcinomas: a study of 62 cases. , 1998, Annals of surgery.
[31] M. Gonen,et al. Staging, Resectability, and Outcome in 225 Patients With Hilar Cholangiocarcinoma , 2001, Annals of surgery.
[32] L. Blumgart,et al. Hilar Cholangiocarcinoma: A Review and Commentary , 2000, Annals of Surgical Oncology.
[33] M. Pruckmayer,et al. The role of chemotherapy and radiation in the management of biliary cancer: a review of the literature. , 1998, European journal of cancer.
[34] B. I. Choi,et al. Preoperative evaluation of Klatskin tumor: accuracy of spiral CT in determining vascular invasion as a sign of unresectability , 2000, Abdominal Imaging.
[35] S. Hansen,et al. [Detection of cholangiocarcinoma in primary sclerosing cholangitis by positron emission tomography]. , 2000, Ugeskrift for laeger.
[36] M. Manns,et al. K-ras mutations in the bile of patients with primary sclerosing cholangitis , 2001, Gut.
[37] N. Aronson,et al. Evidence-based assessment of ERCP approaches to managing pancreaticobiliary malignancies. , 2002, Gastrointestinal endoscopy.
[38] N. Soehendra,et al. EUS-guided fine-needle aspiration cytodiagnosis of hilar cholangiocarcinoma: a case series. , 2000, Gastrointestinal endoscopy.
[39] M. Nagino,et al. Lymph Node Metastasis from Hilar Cholangiocarcinoma: Audit of 110 Patients Who Underwent Regional and Paraaortic Node Dissection , 2001, Annals of surgery.
[40] S. Kondo,et al. Clinical role of 18F-FDG PET for initial staging of patients with extrahepatic bile duct cancer , 2002, European Journal of Nuclear Medicine and Molecular Imaging.
[41] G. Gores,et al. p16INK4a promoter mutations are frequent in primary sclerosing cholangitis (PSC) and PSC-associated cholangiocarcinoma. , 2002, Gastroenterology.
[42] K. Boberg,et al. Cholangiocarcinoma in situ in primary sclerosing cholangitis: diagnosis by brush cytology and treatment by liver transplantation. , 2003, Journal of hepatology.
[43] F. Prat,et al. Performance characteristics of magnetic resonance cholangiography in the staging of malignant hilar strictures , 2000, Gut.
[44] C. Meyer,et al. Liver transplantation for cholangiocarcinoma: results in 207 patients. , 2000, Transplantation.
[45] P. Kortan,et al. Outcome in patients with bifurcation tumors who undergo unilateral versus bilateral hepatic duct drainage. , 1996, Gastrointestinal endoscopy.
[46] K. Sugano,et al. Transpapillary intraductal US prior to biliary drainage in the assessment of longitudinal spread of extrahepatic bile duct carcinoma. , 2001, Gastrointestinal Endoscopy.
[47] T. Patel. Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States , 2001, Hepatology.
[48] S. Kondo,et al. Clinical role of (18)F-FDG PET for initial staging of patients with extrahepatic bile duct cancer. , 2002, European journal of nuclear medicine and molecular imaging.
[49] M. Ortner,et al. Photodynamic therapy of nonresectable cholangiocarcinoma. , 1998, Gastroenterology.
[50] G. Tytgat,et al. Value of brush cytology for dominant strictures in primary sclerosing cholangitis , 1998, Endoscopy.